Axelar Announces Final Data from Phase II Study with AXL1717 in Lung Cancer

News   Dec 27, 2013

 
Axelar Announces Final Data from Phase II Study with AXL1717 in Lung Cancer
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE